Applied BioCode Corporation (6598.TW) TAI

Currency In TWD

AD

Valuation

Market Cap2.26B
Enterprise Value1.85B
P/E Ratio-73.68
PEG Ratio-0.4
Price/Sales Ratio3.54
Price/Book Ratio3.73
Enterprise/Revenue2.99
Enterprise/EBITDA-92.65

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.05
Operating Margin-0.07
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.05

Income Statement

Revenue475.2M
Revenue/Share6.97
Gross Profit260.89M
EBITDA-166.96M
Net Income-201.2M
Diluted EPS-1.96

Balance Sheet

Total Cash557.34M
Total Cash/Share5.34
Total Debt51.32M
Total Debt/Equity0.07
Current Ratio7.25
Book Value Per Share6.72

Price History

52-Week Change14.65
52-Week High31.9
52-Week Low20.5
Moving Average 50 Days28.07
Moving Average 200 Days25.64

Statistics

Average Volume211,067
Shares Outstanding102.82M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor529:500
Last Split DateJuly 02, 2024
AD